Skip to content
Drug recall · FDA · Published March 19, 2021

Asclemed USA Inc. dba Enovachem Pharmaceuticals recalls Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by:

Enovachem Pharmaceuticals recalls 4mg methylprednisolone tablets with misaligned dosing instructions on blister cards. Consumers should check labels for illegible dosing info to avoid medication errors.

🇺🇸 FDA recall #D-0330-2021DrugEnovachem Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmAsclemed USA Inc. dba Enovachem Pharmaceuticals379 Van Ness Ave Ste 1403, N/A · Torrance, CA 90501-7211
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Enovachem Pharmaceuticals is recalling methylprednisolone tablets that have misaligned dosing instructions on the blister card. This could lead to medication errors if users misread the dosage. Read more at govinfonow.com/recall/36267-enovachem-methylprednisolone-tablets-4mg-recall-illegible-dosing-labels.

Source Summary by GovInfoNow · govinfonow.com/recall/36267-enovachem-methylprednisolone-tablets-4mg-recall-illegible-dosing-labels · Updated October 4, 2026 · FDA enforcement record: FDA #D-0330-2021

Cite this page

“Enovachem Methylprednisolone Tablets 4mg Recall: Illegible Dosing Labels.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36267-enovachem-methylprednisolone-tablets-4mg-recall-illegible-dosing-labels. Based on FDA recall #D-0330-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0330-2021%22&limit=1).

Why it’s dangerous

The dosing instructions on the blister card are misaligned, making them hard to read. This could cause users to take the wrong dose of medication, potentially leading to medication errors.

Who’s affected

People who have the 4mg methylprednisolone tablets with NDC 69306-004-21. Those who rely on these tablets for medical treatment are most at risk of dosage errors.

How to tell if you have this one

Check for the product name 'Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister' with NDC 69306-004-21. The label may show misaligned dosing instructions on the blister card.

  • Brand
    Enovachem Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label

    Look for misaligned dosing instructions on the blister card to confirm if the product is recalled.

✎ GovInfoNow

Questions people ask

Is this product dangerous?

The recall is for misaligned dosing instructions on the blister card, which could lead to medication errors. It is not a safety hazard that causes injury.

How can I tell if I have the recalled product?

Check for the product name 'Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister' with NDC 69306-004-21. The label may show misaligned dosing instructions on the blister card.

What should I do if I have the recalled product?

Check the label for misaligned dosing instructions. If you see this issue, contact your doctor or pharmacist for guidance.

Take action

Contact Enovachem Pharmaceuticals

We’ve drafted a message you can send Enovachem Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-0330-2021 — Enovachem Pharmaceuticals Enovachem Pharmaceuticals

Hello,

I own a Enovachem Pharmaceuticals that is covered by recall D-0330-2021 from Enovachem Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0330-2021 (March 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0330-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA